EX-99 4 exhibit_2.htm 6-K

Exhibit 2

Year ended December 31,
1999
2000
2001
2002
2003
2004
2005
Total
Net Income (loss) - as previously reported     $(1,654 ) $ 6,279   $(41,785 ) $(5,500 ) $ 914   $ 24,150   $ 52,640       
       
Restatement effect:  
    Costs of goods sold    61    156    143    138    261    209    191       
    Research and development, net    192    527    531    447    1,146    1,061    961       
    Selling and marketing    444    1,224    1,145    933    1,729    1,625    2,441       
    General and administrative    139    410    330    183    725    726    673       







Total restatement effect    836    2,317    2,149    1,701    3,861    3,621    4,266    18,751  

                                               







Net Income (loss) - as restated   $(2,490 ) $ 3,962   $(43,934 ) $(7,201 ) $(2,947 ) $ 20,529   $ 48,374       










Year ended December 31, 2003
Year ended December 31, 2004
Year ended December 31, 2005
As previously reported
Adjustments
As restated
As previously reported
Adjustments
As restated
As previously reported
Adjustments
As restated
 
Revenues     $ 130,054   $ 0   $ 130,054   $ 416,560   $ 0   $ 416,560   $ 614,983   $ 0   $ 614,983  









    
Costs and expenses:    
    
     Costs of goods sold       93,114     261     93,375     303,320     209     303,529     462,236     191     462,427  
     Research and development, net       14,714     1,146     15,860     24,834     1,061     25,895     37,456     961     38,417  
     Selling and marketing       19,419     1,729     21,148     31,077     1,625     32,702     33,523     2,441     35,964  
     General and administrative       4,852     725     5,577     6,904     726     7,630     12,143     673     12,816  
     In-process research and development write off       0     0     0     0     0     0     2,460     0     2,460  









    
     Total costs and expenses       132,099     3,861     135,960     366,135     3,621     369,756     547,818     4,266     552,084  









    
     Operating income (loss)       (2,045 )   (3,861 )   (5,906 )   50,425     (3,621 )   46,804     67,165     (4,266 )   62,899  
     Financial income, net       2,711     0     2,711     3,920     0     3,920     8,688     0     8,688  
     Other income, net       131     0     131     183     0     183     6,325     0     6,325  









    
Income (loss) before taxes on income       797     (3,861 )   (3,064 )   54,528     (3,621 )   50,907     82,178     (4,266 )   77,912  
Taxes on income       0     0     0     0     0     0     156     0     156  









    
Income (loss) after taxes on income       797     (3,861 )   (3,064 )   54,528     (3,621 )   50,907     82,022     (4,266 )   77,756  
Equity in losses of an affiliate       0     0     0     0     0     0     3,146     0     3,146  
Minority interest in losses (earnings) of subsidiaries       (117 )   0     (117 )   30,378     0     30,378     26,236     0     26,236  









     
Net income (loss)     $ 914   $ (3,861 ) $ (2,947 ) $ 24,150   $ (3,621 ) $ 20,529   $ 52,640   $ (4,266 ) $ 48,374  









     
Basic net earnings (loss) per share     $ 0.03   $ (0.13 ) $ (0.10 ) $ 0.71   $ (0.11 ) $ 0.60   $ 1.46   $ (0.12 ) $ 1.34  









     
Diluted net earnings (loss) per share     $ 0.03   $ (0.13 ) $ (0.10 ) $ 0.66   $ (0.10 ) $ 0.56   $ 1.30   $ (0.10 ) $ 1.20  









     
     Weighted average number of Ordinary Shares used in    
     computing basic net earnings (loss) per share       28,178,228     0     28,178,228     34,195,642     0     34,195,642     36,164,979     0     36,164,979  









     
     Weighted average number of Ordinary Shares used in    
     computing diluted net earnings (loss) per share       30,513,485     (2,335,257 )   28,178,228     36,823,118     (475,177 )   36,347,941     41,156,678     (317,983 )   40,838,695